Valproic acid exhibits biphasic effects on apoptotic cell death of activated lymphocytes through differential modulation of multiple signaling pathways

References

• Al Zaid Siddiquee, K., and Turkson, J. 2008. STAT3 as a target for inducing apoptosis in solid and hematological tumors. Cell Res. 18:254–267.
   PubMed Web of Science ®Google Scholar
• Bill, M. A., Fuchs, J. R., Li, C., Yui, J., Bakan, C., Benson, D. M. Jr, Schwartz, E. B., Abdelhamid, D., Lin, J., Hoyt, D. G., Fossey, S. L., Young, G. S., Carson, W. E., 3rd, Li, P. K., and Lesinski, G. B. 2010. The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity. Mol Cancer. 9:165.
   PubMedGoogle Scholar
• Brogdon, J. L., Xu, Y., Szabo, S. J., An, S., Buxton, F., Cohen, D., and Huang, Q. 2007. Histone deacetylase activities are required for innate immune cell control of TH1 but not TH2 effector cell function. Blood 109:1123–1130.
   PubMed Web of Science ®Google Scholar
• Cinatl, J., Jr, Kotchetkov, R., Blaheta, R., Driever, P. H., Vogel, J. U., and Cinatl, J. 2002. Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: Enhancement by combination with interferon-alpha. Int J Oncol. 20:97–106.
   PubMed Web of Science ®Google Scholar
• Coyle, T. E., Bair, A. K., Stein, C., Vajpayee, N., Mehdi, S., and Wright, J. 2005. Acute leukemia associated with valproic acid treatment: A novel mechanism for leukemogenesis? Am J Hematol. 78:256–260.
   PubMed Web of Science ®Google Scholar
• Fortunati, N., Catalano, M. G., Arena, K., Brignardello, E., Piovesan, A., and Boccuzzi, G. 2004. Valproic acid induces the expression of the Na+/I− symporter and iodine uptake in poorly differentiated thyroid cancer cells. J Clin Endocrinol Metab. 89:1006–1009.
   PubMed Web of Science ®Google Scholar
• Hashimoto, R., Hough, C., Nakazawa, T., Yamamoto, T., and Chuang, D. M. 2002. Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: Involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. J Neurochem. 80:589–597.
   PubMed Web of Science ®Google Scholar
• Jeong, M. R., Hashimoto, R., Senatorov, V. V., Fujimaki, K., Ren, M., Lee, M. S., and Chuang, D. M. 2003. Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: A role of histone deacetylase inhibition. FEBS Lett. 542:74–78.
   PubMed Web of Science ®Google Scholar
• Johannessen, C. U., and Johannessen, S. I. 2003. Valproate: Past, present, and future. CNS Drug Rev. 9:199–216.
   PubMedGoogle Scholar
• Kawagoe, R., Kawagoe, H., and Sano, K. 2002. Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and -independent apoptotic signaling pathways. Leuk Res. 26:495–502.
   PubMed Web of Science ®Google Scholar
• Lee, J. H., Choy, M. L., Ngo, L., Foster, S. S., and Marks, P. A. 2010. Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair. Proc Natl Acad Sci USA. 107:14639–14644.
   PubMed Web of Science ®Google Scholar
• Mackey, T. J., Borkowski, A., Amin, P., Jacobs, S. C., and Kyprianou, N. 1998. Bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer. Urology 52:1085–1090.
   PubMed Web of Science ®Google Scholar
• Marchion, D. C., Bicaku, E., Daud, A. I., Sullivan, D. M., and Munster, P. N. 2005. Valproic acid alters chromatin structure by regulation of chromatin modulation proteins. Cancer Res. 65:3815–3822.
   PubMed Web of Science ®Google Scholar
• Michaelis, M., Suhan, T., Michaelis, U. R., Beek, K., Rothweiler, F., Tausch, L., Werz, O., Eikel, D., Zörnig, M., Nau, H., Fleming, I., Doerr, H. W., and Cinatl, J., Jr. 2005. Valproic acid induces extracellular signal-regulated kinase-1/2 activation and inhibits apoptosis in endothelial cells. Cell Death Differ. 13:446–453.
   Google Scholar
• Nencioni, A., Beck, J., Werth, D., Grünebach, F., Patrone, F., Ballestrero, A., and Brossart, P. 2007. Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity. Clin Cancer Res. 13:3933–3941.
   PubMed Web of Science ®Google Scholar
• Ogbomo, H., Michaelis, M., Kreuter, J., Doerr, H. W., and Cinatl, J., Jr. 2007. Histone deacetylase inhibitors suppress natural killer cell cytolytic activity. FEBS Lett. 581:1317–1322.
   Google Scholar
• Perandones, C. E., Illera, V. A., Peckham, D., Stunz, L. L., and Ashman, R. F. 1993. Regulation of apoptosis in vitro in mature murine spleen T-cells. J Immunol. 151:3521–3529.
   PubMed Web of Science ®Google Scholar
• Pérez, M., Rojo, A. I., Wandosell, F., Díaz-Nido, J., and Avila, J. 2003. Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3. Biochem J. 372:129–136.
   PubMedGoogle Scholar
• Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., and Klein, P. S. 2001. Histone deacetylase is a direct target of valproic acid, a potent anti-convulsant, mood stabilizer, and teratogen. J Biol Chem. 276:36734–36741.
   PubMed Web of Science ®Google Scholar
• Skov, S., Rieneck, K., Bovin, L. F., Skak, K., Tomra, S., Michelsen, B. K., and Ødum N. 2003. Histone deacetylase inhibitors: A new class of immunosuppressors targeting a novel signal pathway essential for CD154 expression. Blood 101:1430–1438.
   PubMed Web of Science ®Google Scholar
• Smith, K. T., and Workman, J. L. 2009. Histone deacetylase inhibitors: Anticancer compounds. Int J Biochem Cell Biol. 41:21–25.
   PubMed Web of Science ®Google Scholar
• Takai, N., Desmond, J. C., Kumagai, T., Gui, D., Said, J. W., Whittaker, S., Miyakawa, I., and Koeffler, H. P. 2004. Histone deacetylase inhibitors have a profound anti-growth activity in endometrial cancer cells. Clin Cancer Res. 10:1141–1149.
   PubMed Web of Science ®Google Scholar
• Tao, R., de Zoeten, E. F., Ozkaynak, E., Chen, C., Wang, L., Porrett, P. M., Li, B., Turka, L. A., Olson, E. N., Greene, M. I., Wells, A. D., and Hancock, W. W. 2007. Deacetylase inhibition promotes the generation and function of regulatory T-cells. Nat Med. 13:1299–1307.
   PubMed Web of Science ®Google Scholar
• Vacotto, M., Coso, O., and Fiszer de Plazas, S. 2008. Programmed cell death and differential JNK, p38, and ERK response in a prenatal acute hypoxic hypoxia model. Neurochem Int. 52:857–863.
   Google Scholar
• Williams, R. S., Cheng, L., Mudge, A. W., and Harwood, A. J. 2002. A common mechanism of action for three mood-stabilizing drugs. Nature 417:292–295.
   PubMed Web of Science ®Google Scholar
• Xie, N., Wang, C., Lin, Y., Li, H., Chen, L., Zhang, T., Sun, Y., Zhang, Y., Yin, D., and Chi, Z. 2010. The role of p38 MAPK in valproic acid induced microglia apoptosis. Neurosci Lett. 482:51–56.
   Google Scholar
• Xu, W. B., Xu, L. H., Lu, H. S., Ou-Yang, D. Y., Shi, H. J., Di, J. F., and He, X. H. 2009. The immunosuppressive effect of gossypol in mice is mediated by inhibition of lymphocyte proliferation and by induction of cell apoptosis. Acta Pharmacol Sin. 30:597–604.
   Google Scholar